Related Experiment Video
Updated: May 21, 2025

Organotypic Retinal Explant Cultures from Macaque Monkey
Published on: August 24, 2022
Pten Loss Triggers Progressive Photoreceptor Degeneration in an mTORC1-Independent Manner
Joseph Hanna1,2,3, Yacine Touahri1,3,4, Alissa Pak1,2
1Biological Sciences Platform, Sunnybrook Research Institute, Toronto, Ontario, Canada.
Purpose:
Silencing Phosphatase and tensin homolog (Pten) is a proposed therapeutic strategy for tissue regeneration to treat neurological disorders. However, Pten is pleiotropic, inhibiting several signaling and metabolic pathways, including mTORC1 and glycolysis, both pro-regenerative in certain contexts. This study aims to assess the long-term impact of inactivating Pten on photoreceptor survival in the retina and to identify downstream pathway(s).
Methods:
We assessed retinal integrity in Pten conditional knock-outs (cKOs) that were retinal progenitor cell (RPC)-specific (Pten RPC-cKO), a congenital model, or rod-specific (Pten Rho-cKO). We examined early changes in photoreceptor gene expression and used immunostaining to assess photoreceptors, reactive astrocytes, microglia, angiogenesis, and subretinal deposit formation from postnatal day (P) 21 to 1 year of age. Pten RPC-cKO retinal explants were treated with rapamycin, an mTOR inhibitor, or 2-deoxy-D-glucose (2DG), a glycolysis inhibitor.
Results:
In both Pten-cKO models, retinas display signs of early pathogenesis as photoreceptor-specific gene expression is downregulated at P0, before photoreceptor loss. Pten loss triggers progressive rod and cone degeneration beginning at P21 in Pten RPC-cKOs and at 6 months of age in Pten Rho-cKOs. Activated microglia and astrocytes, and increased angiogenesis, are observed in both Pten-cKO models, while subretinal amyloid-β deposits develop in Pten RPC-cKOs. Rapamycin accelerates photoreceptor degeneration in Pten RPC-cKOs, whereas 2DG has no effect.
Conclusions:
Our findings suggest that Pten loss, either in RPCs as a congenital model, or solely in mature rod photoreceptors, leads to progressive retinal degeneration that is exacerbated by mTORC1 suppression, drawing into question the therapeutic value of Pten-mTORC1 manipulations.
Insights
Silencing Phosphatase and tensin homolog (Pten) in the retina causes progressive photoreceptor degeneration, challenging its use for neurological disorder treatments. mTORC1 suppression worsens this degeneration, indicating Pten-mTORC1 pathway manipulation may not be therapeutic.
Area of Science:
- Ophthalmology
- Neuroscience
- Cell Biology
Background:
- Phosphatase and tensin homolog (Pten) is a key regulator of cell signaling and metabolism.
- Pten inhibition is explored for tissue regeneration in neurological disorders.
- Pten influences mTORC1 and glycolysis, pathways relevant to regeneration.
Purpose of the Study:
- To investigate the long-term effects of Pten inactivation on retinal photoreceptor survival.
- To identify downstream signaling pathways affected by Pten loss in the retina.
Main Methods:
- Assessed retinal integrity in Pten conditional knock-out (cKO) mouse models (RPC-specific and rod-specific).
- Examined photoreceptor gene expression, cell survival, and glial activation.
- Investigated the impact of mTORC1 inhibition (rapamycin) and glycolysis inhibition (2DG) on Pten-deficient retinas.
Main Results:
- Pten loss led to early downregulation of photoreceptor genes and progressive rod and cone degeneration.
- Inactivated Pten induced retinal inflammation, astrogliosis, microgliosis, and increased angiogenesis.
- Subretinal amyloid-beta deposits formed in Pten RPC-cKOs.
- Rapamycin accelerated photoreceptor degeneration, while 2DG had no significant effect.
Conclusions:
- Pten inactivation in retinal progenitor cells or mature rod photoreceptors causes retinal degeneration.
- The pro-regenerative role of mTORC1 is confirmed, as its suppression exacerbates Pten-loss-induced degeneration.
- Therapeutic strategies targeting Pten and mTORC1 for retinal regeneration require careful consideration.
Related Concept Videos
PI3K/mTOR/AKT Signaling Pathway
mTOR Signaling and Cancer Progression
The mTOR pathway or the...
The Retinoblastoma Gene
The first-ever tumor suppressor gene called Rb was identified in retinoblastoma - a rare eye tumor in children. In inherited forms of the disease, a child inherits one defective copy of the Rb gene, which predisposes them to retinoblastoma. However,...
Photoreceptors and Visual Pathways
Abnormal Proliferation

